Regulatory PathRegulatory requirements compared

Active substance

Dutasteride

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
AVODART 0.5MG CAPSULE0.5 mgCapsule · Oral use30 BlisterSAR 111.90NCE · PrescriptionGLAXO SAUDI ARABIAValid
Duserex0.5 mgCapsule, soft · Oral use30 BlisterSAR 81.80Generic · PrescriptionMS Pharma Saudi (MSPS)Valid
Dusta0.5 mgCapsule, soft · Oral use30 BlisterSAR 90.90Generic · PrescriptionJazeera Pharmaceutical Industries (JPI)Valid
Indications — CHI Daman Drug Formulary

BENIGN PROSTATIC HYPERTROPHY

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
AVODART0.5MGcapsule · oralWAYLIS THERAPPrescription20 Nov 2001
DUTASTERIDE0.5MGcapsule · oralBARRPrescription21 Dec 2010
DUTASTERIDE0.5MGcapsule · oralCHARTWELLPrescription20 Nov 2015
DUTASTERIDE0.5MGcapsule · oralAUROBINDO PHARMA LTDPrescription20 Nov 2015
DUTASTERIDE0.5MGcapsule · oralAMNEAL PHARMSPrescription20 Nov 2015
DUTASTERIDE0.5MGcapsule · oralONESOURCEPrescription20 Nov 2015
DUTASTERIDE0.5MGcapsule · oralACELLAPrescription17 Mar 2016
DUTASTERIDE0.5MGcapsule · oralASCENT PHARMS INCPrescription21 Oct 2016
DUTASTERIDE0.5MGcapsule · oralMARKSANS PHARMAPrescription7 Apr 2017
DUTASTERIDE0.5MGcapsule · oralZYDUS LIFESCIENCESPrescription4 Oct 2017
DUTASTERIDE0.5MGcapsule · oralHUMANWELL PURACAPPrescription21 Nov 2017
DUTASTERIDE0.5MGcapsule · oralPH HEALTHDiscontinued20 Nov 2015
DUTASTERIDE0.5MGcapsule · oralRISINGDiscontinued20 Nov 2015
DUTASTERIDE0.5MGcapsule · oralACTAVIS LABS FL INCDiscontinued20 Nov 2015
DUTASTERIDE0.5MGcapsule · oralPHARMOBEDIENTDiscontinued20 Nov 2015
DUTASTERIDE0.5MGcapsule · oralHIKMA PHARMSDiscontinued23 Nov 2015
DUTASTERIDE0.5MGcapsule · oralAPOTEXDiscontinued24 Nov 2015
DUTASTERIDE0.5MGcapsule · oralPHARMOBEDIENTDiscontinued14 Jun 2016
DUTASTERIDE0.5MGcapsule · oralHERITAGE PHARMS INCDiscontinued13 Oct 2017
DUTASTERIDE0.5MGcapsule · oralSTRIDES PHARMADiscontinued22 Jun 2018

Canada Canada — marketed products (Health Canada)

BrandDINStrengthForm · routeCompany
AG-DUTASTERIDE024856720.5 MGCAPSULE · ORALANGITA PHARMA INC.
APO-DUTASTERIDE024042060.5 MGCAPSULE · ORALAPOTEX INC
AURO-DUTASTERIDE024693080.5 MGCAPSULE · ORALAURO PHARMA INC
AVODART022478130.5 MGCAPSULE · ORALGLAXOSMITHKLINE INC
DUTASTERIDE024290120.5 MGCAPSULE · ORALSIVEM PHARMACEUTICALS ULC
DUTASTERIDE024430580.5 MGCAPSULE · ORALSANIS HEALTH INC
JAMP DUTASTERIDE CAPSULES025461670.5 MGCAPSULE · ORALJAMP PHARMA CORPORATION
MINT-DUTASTERIDE024288730.5 MGCAPSULE · ORALMINT PHARMACEUTICALS INC
NRA-DUTASTERIDE024905870.5 MGCAPSULE · ORALNORA PHARMA INC
PRO-DUTASTERIDE025439900.5 MGCAPSULE · ORALPRO DOC LIMITEE
SANDOZ DUTASTERIDE024244440.5 MGCAPSULE · ORALSANDOZ CANADA INCORPORATED
TEVA-DUTASTERIDE024082870.5 MGCAPSULE · ORALTEVA CANADA LIMITED

Prices — United States and England

SourceProduct as listedPriceUnit / packDate
US NADACDUTASTERIDE 0.5 MG CAPSULE$0.15702per EA23 Sep 2026
NHS Drug TariffDutasteride 500microgram capsules£2.4530 capsule1 Oct 2026

NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.

Safety signals and safety-related labeling changes

All safety entries for dutasteride →

Combinations containing Dutasteride

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.